HealthcareEconomy
China's Drug Approvals Surpass 2025 Total in H1 2026
China approved 11 domestically developed new-target drugs in H1 2026, exceeding 2025's total, with world-first therapies and record out-licensing deals.
—4 min read
Tag
#Pharmaceutical Innovation
2 articles
ScienceHealth
China's Marine Drugs Account for Nearly 30% of Global Market
Chinese-developed ocean drugs account for nearly 30% of approved marine drugs globally, as Beijing issues landmark policy to boost the sector.
—5 min read